Skip to content

Omeros OMER Book value per share

Book value per share at other companies

Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$10.76-1.9%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$23.29+2,285%
Immunome logo
ImmunomeIMNM
$5.20+34.5%
Vor Biopharma logo
Vor BiopharmaVOR
-$3.50-133%
Annexon logo
AnnexonANNX
$1.05-36.0%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$4.18-22.6%

Other financials

Income statement

See full
Revenue$9.9M
Gross profit$29.7M
Operating income-$40.9M-9.2%
Net income$56.1M+268%
EPS (diluted)-$0.59-20.4%

Balance sheet

See full
Cash & equivalents$1.9M-55.3%
Total debt$13.5M-30.3%
Total equity-$63.3M+70.3%
Total assets$286.2M+21.7%

Cash flow

See full
Operating cash flow-$14.5M+59.5%
CapEx--100%
Free cash flow-$14.5M+59.6%

Valuation

See full
Market cap$775.86M+313%
P/S8.6×

Profitability

See full
Gross margin98.9%
Operating margin-181.8%
Net margin-136.6%
FCF margin-121.6%

Returns & leverage

See full
Return on equity86.6%
Debt / equity0.3×-1.1×
Current ratio+1.9×

Where this comes from

Calculated from Omeros’s reported figures.

Based on the most recent quarter.

The official record: Omeros’s 10-Q, filed August 9, 2023, on SEC EDGAR. View the filing →

Ask your AI about Omeros's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omeros's book value per share?
Omeros (OMER) reported book value per share of $0.33 in Q2 2023.
How has Omeros's book value per share changed year-over-year?
Omeros's book value per share increased by 162.6% year-over-year, from -$0.52 to $0.33.
What is the long-term trend for Omeros's book value per share?
Over 2 years (2020 to 2022), Omeros's book value per share has grown at a -19.6% compound annual growth rate (CAGR), from -$2.11 to $1.37.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.